Small molecule compound
Product Name
CAS Number
Specification
TP
DMF
Status
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
In-house
√
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
In-house
√
Trametinib dimethyl sulfoxide
1187431-43-1
In-house
Q4 2025
Tofacitinib Citrate
540737-29-9
In-house
√
Acalabrutinib
1420477-60-6
Q4 2025
Q2 2026
Alpelisib
1217486-61-7
Q4 2025
Q2 2026
Apalutamide
956104-40-8
Q3 2025
Q1 2026
Avapritinib
1703793-34-3
Q4 2025
Q2 2026
Capmatinib
1029712-80-8
Q4 2025
Q2 2026
Darolutamide
1297538-32-9
Q4 2025
Q2 2026
Deucravacitinib
1609392-27-9
Q4 2025
Q2 2026
Encorafenib
1269440-29-0
Q4 2025
Q2 2026
Fedratinib
936091-26-8
Q4 2025
Q2 2026
Gilteritinib
1254053-43-4
Q4 2025
Q2 2026
Inavolisib
2060571-02-8
Q4 2025
Q2 2026
Lapatinib
231277-92-9
Q4 2025
Q2 2026
Lorlatinib
1454846-35-5
Q3 2025
Q1 2026
Pazopanib
444731-52-6
Q1 2026
Q3 2026
Ribociclib
1211441-98-3
Q3 2025
Q1 2026